Outcomes in adults with bicuspid aortic valves
- PMID: 18799444
- DOI: 10.1001/jama.300.11.1317
Outcomes in adults with bicuspid aortic valves
Abstract
Context: Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population. Cardiac outcomes in a contemporary population of adults with bicuspid aortic valve have not been systematically determined.
Objective: To determine the frequency and predictors of cardiac outcomes in a large consecutive series of adults with bicuspid aortic valve.
Design, setting, and participants: Cohort study examining cardiac outcomes in 642 consecutive ambulatory adults (mean [SD] age, 35 [16] years; 68% male) with bicuspid aortic valve presenting to a Canadian congenital cardiac center from 1994 through 2001 and followed up for a mean (SD) period of 9 (5) years. Frequency and predictors of major cardiac events were determined by multivariate analysis. Mortality rate in the study group was compared with age- and sex-matched population estimates.
Main outcome measures: Mortality and cause of death were determined. Primary cardiac events were defined as the occurrence of any of the following complications: cardiac death, intervention on the aortic valve or ascending aorta, aortic dissection or aneurysm, or congestive heart failure requiring hospital admission during the follow-up period.
Results: During the follow-up period, there were 28 deaths (mean [SD], 4% [1%]). One or more primary cardiac events occurred in 161 patients (mean [SD], 25% [2%]), which included cardiac death in 17 patients (mean [SD], 3% [1%]), intervention on aortic valve or ascending aorta in 142 patients (mean [SD], 22% [2%]), aortic dissection or aneurysm in 11 patients (mean [SD], 2% [1%]), or congestive heart failure requiring hospital admission in 16 patients (mean [SD], 2% [1%]). Independent predictors of primary cardiac events were age older than 30 years (hazard ratio [HR], 3.01; 95% confidence interval [CI], 2.15-4.19; P<.001), moderate or severe aortic stenosis (HR, 5.67; 95% CI, 4.16-7.80; P<.001), and moderate or severe aortic regurgitation (HR, 2.68; 95% CI, 1.93-3.76; P<.001). The 10-year survival rate of the study group (mean [SD], 96% [1%]) was not significantly different from population estimates (mean [SD], 97% [1%]; P = .71). At last follow-up, 280 patients (mean [SD], 45% [2%]) had dilated aortic sinus and/or ascending aorta.
Conclusions: In this study population of young adults with bicuspid aortic valve, age, severity of aortic stenosis, and severity of aortic regurgitation were independently associated with primary cardiac events. Over the mean follow-up duration of 9 years, survival rates were not lower than for the general population.
Comment in
-
Valve calcification and patients with bicuspid aortic valves.JAMA. 2009 Mar 4;301(9):935-6; author reply 936. doi: 10.1001/jama.2009.118. JAMA. 2009. PMID: 19258582 No abstract available.
Similar articles
-
Bicuspid aortic valve outcomes.Cardiol Young. 2017 Apr;27(3):518-529. doi: 10.1017/S1047951116002560. Epub 2016 Dec 12. Cardiol Young. 2017. PMID: 27938448
-
Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta.Congenit Heart Dis. 2014 May-Jun;9(3):235-43. doi: 10.1111/chd.12109. Epub 2013 Jun 14. Congenit Heart Dis. 2014. PMID: 23764014
-
Sex Differences and Survival in Adults With Bicuspid Aortic Valves: Verification in 3 Contemporary Echocardiographic Cohorts.J Am Heart Assoc. 2016 Sep 29;5(10):e004211. doi: 10.1161/JAHA.116.004211. J Am Heart Assoc. 2016. PMID: 27688238 Free PMC article.
-
Bicuspid aortic valve disease.J Am Coll Cardiol. 2010 Jun 22;55(25):2789-800. doi: 10.1016/j.jacc.2009.12.068. J Am Coll Cardiol. 2010. PMID: 20579534 Review.
-
Surgical thresholds for bicuspid aortic valve associated aortopathy.JACC Cardiovasc Imaging. 2013 Dec;6(12):1311-20. doi: 10.1016/j.jcmg.2013.10.005. JACC Cardiovasc Imaging. 2013. PMID: 24332283 Review.
Cited by
-
Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis-We Need a Well-Designed Randomized Control Trial.J Clin Med. 2024 Oct 31;13(21):6565. doi: 10.3390/jcm13216565. J Clin Med. 2024. PMID: 39518704 Free PMC article. Review.
-
Incidence and predictors of continued ascending aortic dilatation after TAVI in patients with bicuspid aortic stenosis.Clin Res Cardiol. 2024 Sep 19. doi: 10.1007/s00392-024-02545-9. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39297943
-
Management of aortic disease in children with FBN1-related Marfan syndrome.Eur Heart J. 2024 Oct 14;45(39):4156-4169. doi: 10.1093/eurheartj/ehae526. Eur Heart J. 2024. PMID: 39250726 Free PMC article. Review.
-
Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease.J Soc Cardiovasc Angiogr Interv. 2022 Oct 11;1(6):100506. doi: 10.1016/j.jscai.2022.100506. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132366 Free PMC article. Review.
-
Regional aortic wall shear stress increases over time in patients with a bicuspid aortic valve.J Cardiovasc Magn Reson. 2024 Aug 2;26(2):101070. doi: 10.1016/j.jocmr.2024.101070. Online ahead of print. J Cardiovasc Magn Reson. 2024. PMID: 39096969 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
